Free Trial

ProMIS Neurosciences (PMN) Insider Trading & Ownership

ProMIS Neurosciences logo
$0.96 -0.03 (-3.50%)
(As of 02:24 PM ET)

ProMIS Neurosciences (NASDAQ:PMN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.40%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$177,100.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get PMN Insider Trade Alerts

Want to know when executives and insiders are buying or selling ProMIS Neurosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PMN Insider Buying and Selling by Quarter

ProMIS Neurosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/23/2024Madge K ShafmasterDirectorBuy70,000$1.28$89,600.00  
9/20/2024Madge K ShafmasterDirectorBuy60,000$1.25$75,000.00  
8/14/2024Patrick D KirwinDirectorBuy10,000$1.25$12,500.00  
(Data available from 1/1/2013 forward)

PMN Insider Trading Activity - Frequently Asked Questions

The list of insiders at ProMIS Neurosciences includes Madge K Shafmaster, and Patrick D Kirwin. Learn more on insiders at PMN.

4.40% of ProMIS Neurosciences stock is owned by insiders. Learn more on PMN's insider holdings.

The following insiders have purchased PMN shares in the last 24 months: Madge K Shafmaster ($164,600.00), and Patrick D Kirwin ($12,500.00).

Insiders have purchased a total of 140,000 PMN shares in the last 24 months for a total of $177,100.00 bought.

ProMIS Neurosciences Key Executives

  • Mr. Eugene W. Williams (Age 65)
    Co-Founder & Chairman
    Compensation: $275k
  • Mr. Neil K. Warma M.B.A. (Age 61)
    President, Interim CEO & Director
    Compensation: $40k
  • Dr. Neil R. Cashman M.D. (Age 72)
    Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director
    Compensation: $359.66k
  • Mr. Gavin T. Malenfant (Age 60)
    Chief Operating Officer
    Compensation: $416.73k
  • Mr. Daniel E. Geffken M.B.A. (Age 67)
    Chief Financial Officer
    Compensation: $90.92k
  • Dr. Johanne Kaplan Ph.D. (Age 64)
    Chief Development Officer
    Compensation: $265.81k
  • Dr. Ernest D. Bush Ph.D.
    Head of Pharmacology/Toxicology & Senior Consultant
  • Dr. David Wishart Ph.D.
    Chief Physics Officer
  • Mr. Dennis Chen Ph.D.
    Head of Manufacturing & Senior Consultant
  • Dr. Larry Douglas Altstiel M.D. (Age 74)
    Ph.D., Chief Medical Officer


This page (NASDAQ:PMN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners